HHS leadership worries

Robert F. Kennedy Jr. is no longer a hypothetical choice for the Department of Health and Human Services. The Senate confirmed him on February 13, 2025, and he now leads the federal department that oversees vaccine policy, biomedical research, Medicare, and Medicaid. (senate.gov) The confirmation vote was 52-48, with Senator Mitch McConnell the only Republican to vote no. Congress lists Kennedy’s nomination as PN11-8 for the 119th Congress, and the department’s own budget pages show the agency’s reach across the Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, and Centers for Medicare and Medicaid Services. (congress.gov) (hhs.gov) Warnings about Kennedy’s leadership started before he took office. In a November 20, 2024 article, Chief Healthcare Executive said critics argued that his record on vaccines and his lack of scientific and management experience could weaken trust in public health decisions. (chiefhealthcareexecutive.com) Those concerns have not stayed theoretical. On April 9, 2026, Reuters reported that Kennedy issued a new charter for the Advisory Committee on Immunization Practices, the panel that advises the Centers for Disease Control and Prevention on vaccine use, expanding its role to include vaccine risks and alleged gaps in safety evidence. (usnews.com) The Centers for Disease Control and Prevention says that committee helps develop recommendations on vaccines for the civilian population of the United States. The revised charter came after a Federal Register notice on April 6, 2026 renewed the committee through April 1, 2028. (cdc.gov) (federalregister.gov) Kennedy has also made autism a signature issue inside the department. On September 22, 2025, the Department of Health and Human Services announced autism initiatives with President Donald Trump, including a Food and Drug Administration label update for leucovorin tied to a subset of children with autism spectrum disorder and new National Institutes of Health research. (hhs.gov) On January 28, 2026, the department said Kennedy appointed 21 new members to the Interagency Autism Coordinating Committee. The announcement said the panel would focus on autism research, diagnosis, treatment, and prevention. (hhs.gov) The federal data Kennedy has cited are real, but the interpretation is disputed. The Centers for Disease Control and Prevention said on May 27, 2025 that about 1 in 31 children age 8 had been identified with autism spectrum disorder, up from 1 in 36 in the prior surveillance cycle. (cdc.gov) Researchers and clinicians have long said rising autism prevalence can reflect broader screening, changing diagnostic practice, and better identification, not just a single environmental cause. NBC News reported that point when the 2025 federal data were released. (nbcnews.com) Kennedy and his allies say they are redirecting the department toward chronic disease, food policy, and questions they believe federal health agencies have ignored. The White House’s fiscal year 2027 budget says the administration wants a major reorganization of the department, including a new Administration for a Healthy America. (whitehouse.gov) The core argument around Kennedy has shifted from whether he might run the nation’s health department to how he is using that power. The fight now is over what happens when a secretary who built a political following by challenging vaccine orthodoxy controls the agencies that write the country’s health rules. (chiefhealthcareexecutive.com) (cdc.gov)